関連する実験動画
Updated: Jan 14, 2026

04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
10.7K
分散データ環境におけるデータ連携準実験を用いた共変量バランス生存曲線の推定
Akihiro Toyoda1, Yuji Kawamata2, Tomoru Nakayama1
1Graduate School of Science and Technology, University of Tsukuba, Tsukuba, Japan.
Scientific reports
|January 12, 2026
まとめ
プライバシー保護手法により、機関間での協調的生存分析が可能になります。このフレームワークは低次元データを共有し、生の患者データ交換なしに信頼性の高いカプランマイヤー曲線をもたらします。
科学分野:
- 生物統計学
- ヘルスインフォマティクス
- 医療データプライバシー
背景:
- 患者レベルのデータを生存分析のために共有することは、プライバシー上の懸念から妨げられています。
- 既存の方法では、多くの場合、中央集権化されたデータが必要であり、プライバシーのリスクをもたらします。
研究 の 目的:
- 分散生存分析のためのプライバシー保護フレームワークを提案すること。
- 分散データから、バランスの取れたカプランマイヤー曲線の協調的推定を可能にすること。
主な方法:
- 各機関は、次元削減後に共変量行列の低次元表現を共有します。
- 分析者は、集約されたデータを再構築し、傾向スコアマッチングを実行し、生存曲線を推定します。
- このフレームワークは、水平および垂直の両方のデータ分散をサポートします。
主要な成果:
- 提案手法は、実験において単一施設での分析を一貫して上回りました。
- 生データの開示なしに、信頼性の高い生存曲線推定を実現しました。
- シミュレーションおよび5つの公開医療データセットで有効性が実証されました。
結論:
- このフレームワークは、患者のプライバシーを維持しながら、協調的生存分析を促進します。
- 分散された観察データから、信頼性が高くプライバシーが保護された生存曲線の推定を可能にします。
- 多機関による医療研究のための実用的なソリューションを提供します。
関連する概念動画
Comparing the Survival Analysis of Two or More Groups
548
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
548
Assumptions of Survival Analysis
391
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
391
Censoring Survival Data
518
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
518
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Parametric Survival Analysis: Weibull and Exponential Methods
1.0K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.0K
Kaplan-Meier Approach
556
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
556

